AXQ Capital LP Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

AXQ Capital LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,060 shares of the company’s stock, valued at approximately $320,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Lindbrook Capital LLC lifted its stake in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the period. Signaturefd LLC raised its holdings in shares of Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the period. Finally, Fifth Third Bancorp raised its holdings in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after buying an additional 454 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ACHC. Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. TD Cowen dropped their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada dropped their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $56.31.

Acadia Healthcare Price Performance

Shares of ACHC opened at $28.69 on Monday. The firm has a market cap of $2.67 billion, a price-to-earnings ratio of 9.41, a PEG ratio of 1.46 and a beta of 1.38. The stock has a 50 day moving average of $38.56 and a 200-day moving average of $46.50. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 52 week low of $27.61 and a 52 week high of $82.41.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.